New treatment for advanced prostate cancer developed
July 31st, 2008 Posted in prostate cancer, prostate relatedDuring a recent study Professor Wayne Tilley and Dr Lisa Butler of the University’s Dame Roma Mitchell Cancer Research Laboratories have developed a combination of existing prostate cancer drugs with new drugs at lower doses can be an effective treatment for patients with advanced prostate cancer.
They treated the prostate cancer cells with a combination of drugs including bicalutamide (an anti-androgen that opposes the action of androgen on the tumour), and the inhibitors 17AAG and vorinostat. These new drugs 17AAG and vorinostat can block key cancer survival pathways, but are not particularly effective in killing prostate cancer cells if given alone.
The new treatment could effectively curb disease progression by killing prostate cancer cells.